• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Open: Timing of respiratory virus molecular testing in emergency departments and its association with patient care outcomes: a retrospective obser

tetano

Editor, Senior Moderator
BMJ Open. 2019 Aug 8;9(8):e030104. doi: 10.1136/bmjopen-2019-030104.
[h=1]Timing of respiratory virus molecular testing in emergency departments and its association with patient care outcomes: a retrospective observational study across six Australian hospitals.[/h] Wabe N[SUP]1[/SUP], Li L[SUP]1[/SUP], Dahm MR[SUP]1[/SUP], Lindeman R[SUP]2[/SUP], Yimsung R[SUP]2[/SUP], Clezy K[SUP]3[/SUP], Thomas J[SUP]1[/SUP], Varndell W[SUP]4[/SUP], Westbrook J[SUP]1[/SUP], Georgiou A[SUP]1[/SUP].
[h=3]Author information[/h] 1 Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, North Ryde, New South Wales, Australia. 2 Clinical Operations, NSW Health Pathology, Chatswood, New South Wales, Australia. 3 Infectious Diseases Department, Prince of Wales Hospital, Randwick, New South Wales, Australia. 4 Emergency Department, Prince of Wales Hospital, Randwick, New South Wales, Australia.

[h=3]Abstract[/h] [h=4]OBJECTIVE:[/h] A rapid molecular diagnostic test (RMDT) offers a fast and accurate detection of respiratory viruses, but its impact on the timeliness of care in the emergency department (ED) may depend on the timing of the test. The aim of the study was to determine if the timing of respiratory virus testing using a RMDT in the ED had an association with patient care outcomes.
[h=4]DESIGN:[/h] Retrospective observational study.
[h=4]SETTING:[/h] Linked ED and laboratory data from six EDs in New South Wales, Australia.
[h=4]PARTICIPANTS:[/h] Adult patients presenting to EDs during the 2017 influenza season and tested for respiratory viruses using a RMDT. The timing of respiratory virus testing was defined as the time from a patient's ED arrival to time of sample receipt at the hospital laboratory.
[h=4]OUTCOME MEASURES:[/h] ED length of stay (LOS), >4 hour ED LOS and having a pending RMDT result at ED disposition.
[h=4]RESULTS:[/h] A total of 2168 patients were included. The median timing of respiratory virus testing was 224 min (IQR, 133-349). Every 30 min increase in the timing of respiratory virus testing was associated with a 24.0 min increase in the median ED LOS (95% CI, 21.8-26.1; p<0.001), a 51% increase in the likelihood of staying >4 hours in ED (OR, 1.51; 95% CI, 1.41 to 1.63; p<0.001) and a 4% increase in the likelihood of having a pending RMDT result at ED disposition (OR, 1.04; 95% CI, 1.02 to 1.05; p<0.001) after adjustment for confounders.
[h=4]CONCLUSION:[/h] The timing of respiratory virus molecular testing in EDs was significantly associated with a range of outcome indicators. Results suggest the potential to maximise the benefits of RMDT by introducing an early diagnostic protocol such as triage-initiated testing.
? Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.


[h=4]KEYWORDS:[/h] diagnostic microbiology; infection control; molecular diagnostics

PMID: 31399462 DOI: 10.1136/bmjopen-2019-030104
Free full text
 
Back
Top Bottom